tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Catherine Schulte, 65 are a HOLD (18.01%), 296 are a BUY (81.99%).
Analyst Catherine Schulte, currently employed at BAIRD, carries an average stock price target met ratio of 73.64% that have a potential upside of 22.4% achieved within 284 days.
Catherine Schulte’s has documented 716 price targets and ratings displayed on 14 stocks. The coverage is on Healthcare, Basic Materials sectors.
Most recent stock forecast was given on TECH, Bio-Techne Corp at 26-Jun-2026.
Analyst best performing recommendations are on MRVI (MARAVAI LIFESCIENCES HOLDINGS ).
The best stock recommendation documented was for CSTL (CASTLE BIOSCIENCES) at 8/19/2019. The price target of $27 was fulfilled within 11 days with a profit of $7.5 (38.46%) receiving and performance score of 34.97.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 09-Sep-2026
$165
$20.25 (13.99%)
$185
Buy Since 22-Aug-2024
$190
$45.25 (31.26%)
$185
14 days ago
(27-Aug-2026)
17/24 (70.83%)
$32.31 (20.49%)
77
Buy Since 30-May-2024
$180
$35.25 (24.35%)
$151
14 days ago
(27-Aug-2026)
13/16 (81.25%)
$22.31 (14.15%)
104
Buy Since 09-Oct-2025
$190
$45.25 (31.26%)
$180
14 days ago
(27-Aug-2026)
0/3 (0%)
$32.31 (20.49%)
Buy Since 06-Apr-2026
$172
$27.25 (18.83%)
$148
14 days ago
(27-Aug-2026)
9/11 (81.82%)
$14.31 (9.07%)
38
Which stock is Catherine Schulte most bullish on?
Which stock is Catherine Schulte most reserved on?
What Year was the first public recommendation made by Catherine Schulte?
